Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Ryan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|May 12, 2021
α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathologyMorgan G Stykel, Kayla M Humphries, Evelyn Kamski-Hennekam, et al.
Nature Communications|February 28, 2018
Cardiolipin exposure on the outer mitochondrial membrane modulates α-synucleinTammy Ryan, Vladimir V Bamm, Morgan G Stykel, et al.
BMC Biology|October 10, 2009
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-cateninKaren A M Kennedy, Tammy Porter, Virja Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2009
Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolismScott D Ryan, Shawn N Whitehead, Leigh Anne Swayne, et al.
Human Mutation|June 17, 2014
Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1AJasmin Hettich, Scott D Ryan, Osmar Norberto de Souza, et al.
Cell Reports|January 8, 2025
G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesisMorgan G Stykel, Shehani V Siripala, Eric Soubeyrand, et al.
Cell Death & Disease|April 4, 2024
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis A Parmasad, Konrad M Ricke, Benjamin Nguyen, et al.
Cell|December 3, 2013
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcriptionScott D Ryan, Nima Dolatabadi, Shing Fai Chan, et al.
Nature Communications|November 15, 2017
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autismShichun Tu, Mohd Waseem Akhtar, Rosa Maria Escorihuela, et al.
The Journal of Clinical Investigation|June 11, 2026
Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizuresMichelle Hua, Mohamad-Reza Aghanoori, Melissa J MacPherson, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|May 12, 2021
α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathologyMorgan G Stykel, Kayla M Humphries, Evelyn Kamski-Hennekam, et al.
Nature Communications|February 28, 2018
Cardiolipin exposure on the outer mitochondrial membrane modulates α-synucleinTammy Ryan, Vladimir V Bamm, Morgan G Stykel, et al.
BMC Biology|October 10, 2009
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-cateninKaren A M Kennedy, Tammy Porter, Virja Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2009
Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolismScott D Ryan, Shawn N Whitehead, Leigh Anne Swayne, et al.
Human Mutation|June 17, 2014
Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1AJasmin Hettich, Scott D Ryan, Osmar Norberto de Souza, et al.
Cell Reports|January 8, 2025
G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesisMorgan G Stykel, Shehani V Siripala, Eric Soubeyrand, et al.
Cell Death & Disease|April 4, 2024
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis A Parmasad, Konrad M Ricke, Benjamin Nguyen, et al.
Cell|December 3, 2013
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcriptionScott D Ryan, Nima Dolatabadi, Shing Fai Chan, et al.
Nature Communications|November 15, 2017
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autismShichun Tu, Mohd Waseem Akhtar, Rosa Maria Escorihuela, et al.
The Journal of Clinical Investigation|June 11, 2026
Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizuresMichelle Hua, Mohamad-Reza Aghanoori, Melissa J MacPherson, et al.
Pageof 4